CHA Biotech Co. Ltd (085660) — Cash Flow Quality Index
CHA Biotech Co. Ltd (085660) has a Cash Flow Quality Index of -4.10x as of March 2026. Operating cash flow of ₩-64.01 Billion is below net income of ₩15.62 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore 085660 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
CHA Biotech Co. Ltd Cash Flow Quality Index (2009–2019)
Historical Cash Flow Quality Index for CHA Biotech Co. Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see CHA Biotech Co. Ltd (085660) cash flow conversion.
Annual Cash Flow Quality Index for CHA Biotech Co. Ltd (2009–2019)
Year-by-year earnings quality comparison for CHA Biotech Co. Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2019 | 0.54x | ₩25.24 Billion | ₩46.37 Billion | ▼ -82.4% |
| 2018 | 3.09x | ₩75.38 Billion | ₩24.39 Billion | ▲ +649.9% |
| 2016 | 0.41x | ₩11.29 Billion | ₩27.40 Billion | ▲ +145.8% |
| 2014 | -0.90x | ₩-2.57 Billion | ₩2.85 Billion | ▼ -134.5% |
| 2013 | 2.61x | ₩66.35 Billion | ₩25.45 Billion | ▲ +39.3% |
| 2012 | 1.87x | ₩45.77 Billion | ₩24.45 Billion | ▼ -78.3% |
| 2011 | 8.64x | ₩34.69 Billion | ₩4.02 Billion | ▲ +4.9% |
| 2010 | 8.24x | ₩42.07 Billion | ₩5.11 Billion | ▲ +86.6% |
| 2009 | 4.41x | ₩24.02 Billion | ₩5.44 Billion | — |